177 related articles for article (PubMed ID: 27510424)
21. Role for dopamine in the behavioral functions of the prefrontal corticostriatal system: implications for mental disorders and psychotropic drug action.
Jentsch JD; Roth RH; Taylor JR
Prog Brain Res; 2000; 126():433-53. PubMed ID: 11105661
[TBL] [Abstract][Full Text] [Related]
22. Have we been ignoring the elephant in the room? Seven arguments for considering the cerebellum as part of addiction circuitry.
Miquel M; Vazquez-Sanroman D; Carbo-Gas M; Gil-Miravet I; Sanchis-Segura C; Carulli D; Manzo J; Coria-Avila GA
Neurosci Biobehav Rev; 2016 Jan; 60():1-11. PubMed ID: 26602022
[TBL] [Abstract][Full Text] [Related]
23. Integrating orbitofrontal cortex into prefrontal theory: common processing themes across species and subdivisions.
Schoenbaum G; Setlow B
Learn Mem; 2001; 8(3):134-47. PubMed ID: 11390633
[TBL] [Abstract][Full Text] [Related]
24. A new proposal for drug conditioning with implications for drug addiction: the Pavlovian two-step from delay to trace conditioning.
Carey RJ; Carrera MP; Damianopoulos EN
Behav Brain Res; 2014 Dec; 275():150-6. PubMed ID: 25218870
[TBL] [Abstract][Full Text] [Related]
25. A computational approach to prefrontal cortex, cognitive control and schizophrenia: recent developments and current challenges.
Cohen JD; Braver TS; O'Reilly RC
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1515-27. PubMed ID: 8941963
[TBL] [Abstract][Full Text] [Related]
26. Episodic future thinking is impaired in the behavioural variant of frontotemporal dementia.
Irish M; Hodges JR; Piguet O
Cortex; 2013 Oct; 49(9):2377-88. PubMed ID: 23582296
[TBL] [Abstract][Full Text] [Related]
27. The synaptic pathology of drug addiction.
Van den Oever MC; Spijker S; Smit AB
Adv Exp Med Biol; 2012; 970():469-91. PubMed ID: 22351069
[TBL] [Abstract][Full Text] [Related]
28. Epigenetics and memory: causes, consequences and treatments for post-traumatic stress disorder and addiction.
Pizzimenti CL; Lattal KM
Genes Brain Behav; 2015 Jan; 14(1):73-84. PubMed ID: 25560936
[TBL] [Abstract][Full Text] [Related]
29. Motivational Processes Underlying Substance Abuse Disorder.
Meyer PJ; King CP; Ferrario CR
Curr Top Behav Neurosci; 2016; 27():473-506. PubMed ID: 26475159
[TBL] [Abstract][Full Text] [Related]
30. Prevention and treatment of drug addiction by environmental enrichment.
Solinas M; Thiriet N; Chauvet C; Jaber M
Prog Neurobiol; 2010 Dec; 92(4):572-92. PubMed ID: 20713127
[TBL] [Abstract][Full Text] [Related]
31. Primate orbitofrontal cortex and adaptive behaviour.
Roberts AC
Trends Cogn Sci; 2006 Feb; 10(2):83-90. PubMed ID: 16380289
[TBL] [Abstract][Full Text] [Related]
32. How the orbitofrontal cortex contributes to decision making - a view from neuroscience.
Volz KG; von Cramon DY
Prog Brain Res; 2009; 174():61-71. PubMed ID: 19477330
[TBL] [Abstract][Full Text] [Related]
33. An fMRI investigation of the relationship between future imagination and cognitive flexibility.
Roberts RP; Wiebels K; Sumner RL; van Mulukom V; Grady CL; Schacter DL; Addis DR
Neuropsychologia; 2017 Jan; 95():156-172. PubMed ID: 27908591
[TBL] [Abstract][Full Text] [Related]
34. Addiction, a condition of compulsive behaviour? Neuroimaging and neuropsychological evidence of inhibitory dysregulation.
Lubman DI; Yücel M; Pantelis C
Addiction; 2004 Dec; 99(12):1491-502. PubMed ID: 15585037
[TBL] [Abstract][Full Text] [Related]
35. Convergence of sensory systems in the orbitofrontal cortex in primates and brain design for emotion.
Rolls ET
Anat Rec A Discov Mol Cell Evol Biol; 2004 Nov; 281(1):1212-25. PubMed ID: 15470678
[TBL] [Abstract][Full Text] [Related]
36. [The role of ventromedial prefrontal cortex in addiction disorders].
Kelemen O; Máttyássy A; Kéri S
Ideggyogy Sz; 2004 Jan; 57(1-2):4-10. PubMed ID: 15042863
[TBL] [Abstract][Full Text] [Related]
37. Deviations of patients with drug addiction value and meaning sphere functioning.
Filts OO; Sedych KV; Lavrinenko VA; Mychailiv SV
Wiad Lek; 2020; 73(4):761-766. PubMed ID: 32731712
[TBL] [Abstract][Full Text] [Related]
38. [Cognitive reserve in substance addicts in treatment: relation to cognitive performance and activities of daily living].
Pedrero-Pérez EJ; Rojo-Mota G; Ruiz-Sánchez de León JM; Fernández-Méndez LM; Morales-Alonso S; Prieto-Hidalgo A
Rev Neurol; 2014 Dec; 59(11):481-9. PubMed ID: 25418142
[TBL] [Abstract][Full Text] [Related]
39. [Ignorance as potential knowledge].
Monrás P
Rev Enferm; 2016; 39(7-8):16-9. PubMed ID: 29582983
[TBL] [Abstract][Full Text] [Related]
40. Refusing to imagine? On the possibility of psychogenic aphantasia. A commentary on Zeman et al. (2015).
de Vito S; Bartolomeo P
Cortex; 2016 Jan; 74():334-5. PubMed ID: 26195151
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
